Detalles de la búsqueda
1.
Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki67.
Prostate
; 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38629249
2.
Safety and efficacy associated with single-fraction high-dose-rate brachytherapy in localized prostate cancer: a systematic review and meta-analysis.
Strahlenther Onkol
; 199(6): 525-535, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37093230
3.
The tumor-repressing effect of CYP27A1 on renal cell carcinoma by 27-HC arising from cholesterol metabolism.
FASEB J
; 36(9): e22499, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35969149
4.
Plasma Exosomal AKR1C3 mRNA Expression Is a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant Prostate Cancer.
Oncologist
; 27(11): e870-e877, 2022 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36067250
5.
Peptide-Derived Biosensors and Their Applications in Tumor Immunology-Related Detection.
Anal Chem
; 94(1): 431-441, 2022 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34846861
6.
Controlled Recognition and Corona Formation by Cascade Micellar Nanoprobes: for Boosting Glioma Theranostics.
Anal Chem
; 94(32): 11118-11123, 2022 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35880859
7.
Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P).
BMC Med
; 20(1): 237, 2022 07 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35864546
8.
Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate.
BJU Int
; 129(3): 345-355, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34185954
9.
MOF derived core-shell CuO/C with temperature-controlled oxygen-vacancy for real time analysis of glucose.
J Nanobiotechnology
; 20(1): 507, 2022 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36456946
10.
The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first-line therapy for patients with metastatic castration-resistant prostate cancer.
Prostate
; 81(15): 1191-1201, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34435696
11.
AgInSe2-Sensitized ZnO Nanoflower Wide-Spectrum Response Photoelectrochemical/Visual Sensing Platform via Au@Nanorod-Anchored CeO2 Octahedron Regulated Signal.
Anal Chem
; 92(11): 7604-7611, 2020 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32364705
12.
The Impact of Renal Impairment on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors.
Cancer Control
; 27(1): 1073274820977143, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33269597
13.
The influence of dynamic changes in lipid metabolism on survival outcomes in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors.
Jpn J Clin Oncol
; 50(12): 1454-1463, 2020 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32719852
14.
The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis.
World J Surg Oncol
; 18(1): 42, 2020 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32093688
15.
AKR1C3 expression in primary lesion rebiopsy at the time of metastatic castration-resistant prostate cancer is strongly associated with poor efficacy of abiraterone as a first-line therapy.
Prostate
; 79(13): 1553-1562, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31294486
16.
Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?
Prostate
; 79(14): 1673-1682, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31433509
17.
The Prognostic Value of the Proportion and Architectural Patterns of Intraductal Carcinoma of the Prostate in Patients with De Novo Metastatic Prostate Cancer.
J Urol
; 201(4): 759-768, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30652989
18.
Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma.
BMC Cancer
; 19(1): 360, 2019 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30992011
19.
Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma.
BMC Cancer
; 19(1): 49, 2019 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30630458
20.
Novel nomograms for castration-resistant prostate cancer and survival outcome in patients with de novo bone metastatic prostate cancer.
BJU Int
; 122(6): 994-1002, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29772102